Brief: Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer
11/09/2025 22:21
Sept 11 (Reuters) - Achieve Life Sciences Inc ACHV.O: ACHIEVE LIFE SCIENCES NAMES DR. MARK RUBINSTEIN INTERIM CHIEF MEDICAL OFFICER Source text: ID:nGNX3wqzWQ Further company coverage: ACHV.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Achieve Life Sciences
See all newsAchieve Life Sciences Q3 net loss and loss per share beat estimates
Brief: Achieve Life Sciences Presents 52-Week Cytisinicline Results For Smoking And Vaping Cessation At Chest 2026
Brief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Achieve Life Sciences Appoints Kaitlyn Tuson As Senior Vice President, Marketing And Communications
Brief: Achieve Life Sciences - Enters ATM Sale Agreement With Jefferies For Up To $150 Million In Common Stock